Related Experiment Video

Updated: Jul 14, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

[Role of antibiotherapy in acute exacerbation of chronic obstructive pulmonary disease]

M Cavassini1, T Calandra, P O Bridevaux

  • 1Service des maladies infectieuses, Département de médecine, CHUV, 101I Lausanne. matthias.cavassini@chuv.ch

Revue Medicale Suisse
|June 20, 2007
PubMed

Insights

Respiratory infections cause most chronic obstructive pulmonary disease (COPD) exacerbations. This review covers antibiotic recommendations for managing moderate to severe COPD exacerbations, improving quality of life and reducing hospitalizations.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Pharmacology

Context:

  • Chronic obstructive pulmonary disease (COPD) exacerbations are frequently triggered by respiratory tract infections.
  • The specific microorganisms involved vary with COPD severity, prior antibiotic use, and previous infections.
  • Current management of moderate to severe COPD exacerbations relies on antibiotics and enhanced bronchodilator therapy.

Purpose:

  • To review current recommendations for antibiotic use in treating COPD exacerbations.
  • To provide guidance on selecting appropriate antibiotic therapy based on causative pathogens and patient factors.

Summary:

  • Antibiotics are crucial for managing moderate to severe COPD exacerbations, which are often infection-driven.
  • Tailoring antibiotic choice to the specific pathogen and patient history is essential.
  • Prompt and appropriate treatment can decrease hospitalization rates and improve patient quality of life.

Impact:

  • Informing clinical practice for optimal management of COPD exacerbations.
  • Potentially reducing the burden of COPD exacerbations on healthcare systems.
  • Improving patient outcomes through evidence-based antibiotic selection.

More Related Videos

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment